Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MLANA Antikörper

MLANA Reaktivität: Human WB, IF, FACS, IHC (f) Wirt: Maus Monoclonal A103-M2-7C10-M2-9E3 unconjugated
Produktnummer ABIN6937860
  • Target Alle MLANA Antikörper anzeigen
    MLANA (Melan A (MLANA))
    Reaktivität
    • 177
    • 103
    • 85
    • 33
    • 15
    Human
    Wirt
    • 91
    • 85
    • 1
    Maus
    Klonalität
    • 108
    • 69
    Monoklonal
    Konjugat
    • 67
    • 15
    • 8
    • 8
    • 8
    • 8
    • 8
    • 8
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Dieser MLANA Antikörper ist unkonjugiert
    Applikation
    • 126
    • 96
    • 95
    • 78
    • 59
    • 52
    • 26
    • 26
    • 22
    • 20
    • 12
    • 10
    • 9
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Spezifität
    This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Seven other melanoma associated antigens recognized by autologous cytotoxic T cells include MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MAb cocktail labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.
    Kreuzreaktivität (Details)
    Human. Mouse. Rat. Dog.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant full-length hMART-1 protein (A103, M2-7C10, M2-9E3)
    Klon
    A103-M2-7C10-M2-9E3
    Isotyp
    IgG2a kappa
    Top Product
    Discover our top product MLANA Primärantikörper
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: SK-MEL-13 and SK-MEL-19 melanoma cell lines. Human melanoma tissues.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    MLANA (Melan A (MLANA))
    Andere Bezeichnung
    MLANA (MLANA Produkte)
    Synonyme
    A930034P04Rik antikoerper, Mart1 antikoerper, MART-1 antikoerper, MART1 antikoerper, melan-A antikoerper, Mlana antikoerper, MLANA antikoerper
    Hintergrund
    Antigen LB39-AA, Antigen SK29-AA, Melanoma antigen recognized by T-cells 1, MLAN-A, MLANA,MART-1 / Melan-A / MLANA (Melanoma Marker)
    Cellular localisation: Cytoplasmic
    Molekulargewicht
    20-22kDa (doublet)
    Gen-ID
    2315, 154069
    UniProt
    Q16655
Sie sind hier:
Kundenservice